Skip to content

“One Big Beautiful Bill”: Trump's Debt Mountain Breaks Records – and Divides Musk and the Republicans

  • News

Washington, July 3, 2025 – The US Congress has opened a controversial chapter in American economic policy with the passage of the “One Big Beautiful Bill” (OBBB), as US President Donald Trump calls his mammoth tax and spending bill. The legislative package, over 900 pages long, which was pushed through the Senate on July 1, 2025, with a narrow majority and the decisive vote of Vice President J.D. Vance, promises tax cuts, massive investments in defense and border security, and cuts to social programs. However, the downside is a dramatic increase in US national debt, which has put even conservative Republicans and tech billionaire Elon Musk on alert. This analysis examines the contents of the bill, its fiscal impact, the political consequences, and the escalating feud between Trump and Musk. Contents of the “One Big Beautiful Bill”: A Bill with Far-Reaching Ambitions The “One Big Beautiful Bill” is a central initiative of Trump's second term, fulfilling his campaign promises… 

Analysis of the cumulative costs of migration policy in Germany from 2015 to 2025

Germany's migration policy, particularly since the so-called refugee crisis of 2015/2016, has significant financial implications for the federal government, the states, and the municipalities. This analysis examines the cumulative costs of migration policy from 2015 to 2025, based on available data, scientific studies, and official reports. It considers direct costs (e.g., for accommodation, care, integration) as well as indirect costs (e.g., social transfers, administration, addressing root causes of flight). The aim is to provide a well-founded and documented overview of the financial burdens incurred by migration policy, while also incorporating critical perspectives to appreciate the complexity of the topic. 1. Background: The Refugee Crisis and its Development In 2015, immigration to Germany reached a historic peak. According to the Federal Office for Migration and Refugees (BAMF), approximately 476,649 asylum applications were filed in 2015, and 745,545 in 2016. In total, around 1.5 million people seeking protection came to Germany in these years, primarily…

Turkey Vacation Cost Trap: High Bills Despite Health Insurance

Munich, July 3, 2025 – Turkey is a popular holiday destination, but for those with statutory health insurance, a doctor's visit can quickly become a cost trap. The European Health Insurance Card (EHIC), which covers emergency medical care within the EU, is not accepted in Turkey. Instead, travelers need a special holiday medical certificate (Form T/A 11), which must be applied for from the health insurance provider in advance. Without this certificate, high costs are threatened, as many vacationers are specifically directed to expensive hotel doctors or private clinics, warns ADAC. "If someone falls ill, the first point of contact for vacationers is usually the hotel doctor," explains Sascha Petzold, Head of Claims at ADAC Versicherung AG. Even with minor complaints like diarrhea, the bills are often inflated: while such treatment costs between 35 and 75 euros in Germany, private doctors in Turkey charge 280 to 380 euros – payable immediately. "This is extremely annoying, brings…

PrivacyWall.org and its significance for biomedicine

  • News

In an era where digital data collection is ubiquitous and the processing of sensitive health data plays a central role in biomedical research, data protection solutions like PrivacyWall.org are gaining increasing importance. The platform, operated by a group of Stanford graduates under the umbrella of Social Game Media Inc., positions itself as a pioneer in the fight against unwanted data collection and offers a search engine as well as privacy tools aimed at protecting user privacy. But what role does PrivacyWall.org play specifically in the context of biomedicine, where the protection of sensitive health data is crucial? This report sheds light on how the platform works, its relevance for biomedical research, and the challenges it faces. PrivacyWall.org: An Overview PrivacyWall.org is more than just a search engine. The platform combines anti-tracking technologies, ad-blocking features, and a unique function called "PrivateView," which allows users to visit websites anonymously without... 

Rare Complication After Radiosurgery: Case Report Reveals Risks of Radiation-Induced Cyst Formation

Bilbao, July 3, 2025 – A research team led by Dr. Iñigo L. Sistiaga from the Cruces University Hospital in Spain has documented a rare but serious case of late complications after stereotactic radiosurgery (SRS) for a brain arteriovenous malformation (AVM). The report, published on January 13, 2025, in the Chinese Neurosurgical Journal, describes how a seemingly harmless cyst years after treatment led to a dangerous chronic hematoma. The findings call for a revision of treatment strategies and emphasize the need for long-term follow-up. An AVM is a vascular malformation in which blood flows directly from arteries to veins without passing through the capillary network. This can damage surrounding brain tissue and cause symptoms such as headaches, seizures, or bleeding. SRS, a precise radiation therapy, is considered an effective, non-invasive treatment, especially for AVMs in sensitive brain regions. However, the long-term risks, such as radiation-induced cyst formation (CF) and chronic encapsulated... 

Biocon Biologics Receives EU Approval for Denosumab Biosimilars

  • News

Bengaluru, July 3, 2025 – Biocon Biologics Ltd. (BBL), a leading global biosimilars company and a subsidiary of Biocon Ltd., has achieved a significant success: The European Commission (EC) has granted marketing authorization for the denosumab biosimilars Vevzuo® and Evfraxy® in the European Union. This approval marks an important step in the company's mission to improve access to essential medicines, particularly in the field of bone health. Vevzuo® is approved for the prevention of bone complications in adults with advanced cancer affecting the bones, as well as for the treatment of giant cell tumors (GCT) of bone in adults and skeletally mature adolescents. Evfraxy®, on the other hand, is indicated for the treatment of osteoporosis in postmenopausal women and men, bone loss in men with prostate cancer undergoing hormone ablation, and bone loss due to long-term glucocorticoid therapy. “The approval of Vevzuo and Evfraxy in Europe underscores our scientific expertise and our commitment to better access… 

Prostate Cancer: BKK Pfalz Covers Costs for mpMRI Early Detection

Ludwigshafen, July 3, 2025 – Prostate cancer is the most common cancer in men in Germany, with around 65,000 new cases annually, and the risk increases with age. BKK Pfalz is now setting new standards in early detection by covering the costs of multiparametric magnetic resonance imaging (mpMRI) of the prostate for its insured members. This innovative, radiation-free procedure enables precise diagnostics that detect tumors early and optimize treatment. The mpMRI provides detailed images of the prostate and can accurately locate aggressive tumor sites. It is used when there is suspicion of prostate cancer during screening – for example, due to an elevated PSA value or an abnormal digital rectal examination. “The earlier a tumor is detected, the better the chances of recovery,” emphasizes Thomas Grausam, Head of Customer Relations at BKK Pfalz. “That's why we are pleased that we can offer our insured members access to this innovative diagnostic procedure – also… 

Innovative nanocomposite hydrogel shows promising results in cartilage regeneration for osteoarthritis treatment

  • News

A research team from Northwest University in China has developed a groundbreaking nanocomposite hydrogel system to tackle the dual challenges of inflammation and cartilage damage in osteoarthritis (OA), one of the most common causes of joint disability worldwide. The study, published in Engineering, confirms that the dual-drug-loaded hydrogel promotes cartilage repair through synergistic immunomodulation and chondrocyte differentiation, offering a novel therapeutic strategy for OA. OA is characterized by persistent inflammation and impaired cartilage regeneration, and existing treatments cannot effectively combat both mechanisms. The newly developed HLC(Dex)–SPNs–KGN hydrogel combines two natural proteins – human-like collagen (HLC) and silk protein nanoparticles (SPNs) – to deliver two key molecules: dexamethasone (Dex), an anti-inflammatory glucocorticoid that suppresses early inflammation and polarizes pro-inflammatory M1 macrophages into anti-inflammatory M2 macrophages; and kartogenin (KGN), which stimulates the differentiation of human mesenchymal stem cells (hMSCs) into chondrocytes and maintains chondrocyte stability in later stages. The hydrogel design enables...

Alzheimer's protein BACE1 identified as key to preventing lung cancer brain metastases

Hamilton/Cleveland, July 3, 2025 – A groundbreaking discovery by researchers at McMaster University, Cleveland Clinic, and Case Comprehensive Cancer Center could revolutionize the treatment of lung cancer brain metastases. In a study published July 2, 2025, in Science Translational Medicine, they reveal how the protein BACE1, long associated with Alzheimer's disease, promotes the spread of lung cancer to the brain. This finding opens the door to repurposing an existing Alzheimer's drug to fight cancer. Brain metastases, tumors that spread from other parts of the body to the brain, occur in up to 40 percent of patients with non-small cell lung cancer and are difficult to treat. "We've always associated BACE1 with Alzheimer's disease, so it's a significant discovery that it plays a central role in lung cancer brain metastases," says Sheila Singh, the study's lead author, director of the McMaster Centre for Discovery in Cancer Research...

Friedrich Merz as "Lying Chancellor": How empty promises endanger democracy

Friedrich Merz, Chancellor of Germany since May 2025 and chairman of the CDU, is being criticized for being a "Lying Chancellor" whose election promises have proven to be empty. Critics accuse him of undermining citizens' trust in democracy through broken promises in the areas of electricity tax, migration, and new debt. This essay examines the accusations against Merz, analyzes his policies in the aforementioned areas, and shows how his actions endanger democratic structures. It is argued that Merz's deceptions and U-turns weaken political credibility and threaten social cohesion. 1. Broken Promises: Electricity Tax, Migration, and New Debt Electricity Tax In the 2025 election campaign, Merz promised a significant reduction in the electricity tax to relieve citizens in the face of rising energy costs. In an interview with ARD on January 15, 2025, he stated that the electricity tax should be "lowered to the European minimum level" to help households and businesses...